The mouse liver is the primary target site for carcinogenesis of more than 200 chemicals (including pesticides. food additives, pharmaceuticals, and industrial intermediates) tested in long-term toxicity safety assessment assays. Mouse liver tumors develop through defined morphological stages (similar to those found in other species) whether their origin is of undetermined etiology (spontaneous) or induced by chemicals. The morphologic type of hepatocytes in the various stages of hepatocarcinogenesis is sometimes associated with the specific inducing agent. Liver tumors developing in toxic livers often have more benign appearances and may progress to carcinomas at a slower rate than tumors developing in histologically normal livers. Specific tumors, dependent on the inducing chemical, may regress under defined protocols. Genotoxic and nongenotoxic mouse hepatocarcinogens each may induce tumors of either high malignant or low malignant potential. Liver tumors with specific H-ras oncogene mutations may appear morphologically and biologically similar to those without proven ras mutations. Thus, distinguishing mechanism of carcinogenesis by liver tumor morphology and mutation spectra may be difficult. Additionally, the presence of liver tumors with a morphology and a ras oncogene mutation spectrum characteristic of spontaneous tumors in histologically normal livers of mice exposed to a nongenotoxic test chemical may indicate promotion of spontaneous hepatocarcinogenesis by one of several potential mechanisms. Further research into the mechanisms responsible for the increased incidences of liver tumors in mice exposed to test chemicals could enhance human cancer risk assessments.
Ames BN, Gold LS, and Willett WC (1995). The causes and prevention of cancer. Proc. Natl. Acad. Sci. USA92: 5258-5265.
2.
Anderson MW and Maronpot RR (1993). Methylene chloride-induced tumorigenesis. Carcinogenesis14: 787-788.
3.
Bucher JR, Shackelford CC, Haseman JK, Johnson JD, Kurtz PJ, and Persing RL (1994). Carcinogenicity studies of oxazepam in mice. Fundam. Appl. Toxicol. 23: 280-297.
4.
Butterworth BE , Slaga TJ, Farland W., and McClain M. (1991). Chemically induced cell proliferation: Implications for risk assessment. Prog. Clin. Biol. Res. 369: 1-546.
5.
Chu KC, Cueto C. Jr, and Ward JM (1981). Factors in the evaluation of 200 National Cancer Institute carcinogen bioassays. J. Toxicol. Environ. Health8: 251-280.
6.
Davies TS and Monro A. (1995). Marketed human pharmaceuticals reported to be tumorigenic in rodents. J. Am. Coll. Toxicol. 14(2): 90-107.
7.
Diwan BA, Ward JM, Kurata Y., and Rice JM (1994). Dissimilar frequency of hepatoblastomas and hepatic cystadenomas and adenocarcinomas arising in hepatocellular neoplasms of D2B6F1 mice initiated with N-nitroso-diethylamine, and subsequently given Aroclor-1254, dichlorodiphenyltrichloroethane, or phenobarbital. Toxicol. Pathol. 22(4): 430-439.
8.
Diwan BA, Ward JM, and Rice JM (1991). Modification of liver tumor development in rodents . In: Modification of Tumor Development in Rodents, N Ito and H Sugano (eds). S Karger, Basel, pp. 76-107.
9.
Dragani TA, Manenti G., and Della Porta G. (1981). Genetic susceptibility to murine hepatocarcinogenesis is associated with high growth rate of NDEA-initiated hepatocytes. J. Cancer Res. Clin. Oncol. 113: 223-229.
10.
Fernandez-Salguero P., Pineau T., Hilbert DM, McPhail T., Lee SST, Kimura S., Nebert DW, Rudikoff S., Ward JM, and Gonzalez FJ (1995). Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science268: 722-726.
11.
Foley JF, Tuck PD, Ton T.-VT, Frost M., Kari F., Anderson MW, and Maronpot RR (1993). Inhalation exposure to a hepatocarcinogenic concentration of methylene chloride does not induce sustained replicative DNA synthesis in hepatocytes of female B6C3F1 mice. Carcinogenesis14: 811-817.
12.
Frith CH and Ward JM (1979). A morphologic classification of proliferative and neoplastic hepatic lesions in mice. J. Environ. Pathol. Toxicol. 3: 329-351.
13.
Frith CH and Ward JM (1988). Color Atlas of Neoplastic and Non-neoplastic Lesions in Aging Mice. Elsevier, Amsterdam , pp. 1-109.
14.
Frith CH, Ward JM, and Turusov VS (1994). Tumours of the liver. In: Pathology of Tumours in Laboratory Animals, V Turusov and U Mohr (eds). International Agency for Research in Cancer, Lyon, France, pp. 223-269.
15.
Fu PP, Dooley KL, Von Tungeln LS, and Bucci T. (1994). Caloric restriction profoundly inhibits liver tumor formation after initiation by 6-nitrochrysene in male mice. Carcinogenesis15(2): 159-161.
16.
Gold LS, Bernstein L., Magaw R., and Slone TH (1989). Interspecies extrapolation in carcinogenesis: Prediction between rats and mice. Environ. Health Perspect . 81: 211-219.
17.
Gold LS, Slone TH, Manley NB, and Bernstein L. (1991). Target organs in chronic bioassays of 533 chemical carcinogens. Environ. Health Perspect. 93: 233-246.
18.
Gold LS, Slone TH, Stern BR, and Bernstein L. (1993). Comparison of target organs of carcinogenicity for mutagenic and non-mutagenic chemicals. Mutat. Res. Fundam. Mol. Mech. Mutagen. 286: 75-100.
19.
Gold LS, Ward JM, Bernstein L., and Stem B. (1986). Association between carcinogenic potency and tumor pathology in rodent carcinogenesis bioassays. Fundam. Appl. Toxicol. 6: 677-690.
20.
Goldfarb S. and Pugh TD (1990). Ovariectomy accelerates the growth of microscopic hepatocellular neoplasms in the mouse: Possible association with whole body growth and fat deposition. Cancer Res. 50: 6779-6782.
21.
Goodman JIWard JMPopp JAKlaunig JE and Fox TR (1991). Mouse liver carcinogenesis: Mechanisms and relevance . Fund. Appl. Toxicol. 17: 651-665.
22.
Harada T.Maronpot RREnomoto A.Tamano S. and Ward JM (1996). Age-related changes in the liver and gallbladder . In: Pathobiology of The Aging Mouse. DL Dungworth.U Mohr.JM Ward, JP Sundberg , and W Carlton (eds). ILSI Press, Washington. D.C. (in press).
23.
Haseman JK, Huff JERao GN, and Eustis SL (1989). Sources of variability in rodent carcinogenicity studies. Fundam. Appl. Toxicol. 12: 793-804.
24.
Hoel DG, Haseman JKHogan MDHuff J. and McConnell EE (1988). The impact of toxicity on carcinogenicity studies: Implications for risk assessment. Carcinogenesis9: 2045-2052.
25.
Huff JE (1995). Mechanisms, chemical carcinogenesis, and risk assessment : Cell proliferation and cancer. Am. J. Ind. Med . 27: 293-300.
26.
Huff J., Cirvello J., Haseman J., and Bucher J. (1991). Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents. Environ. Health Perspect. 93: 247-270.
27.
Huff JE, Eustis SL, and Haseman JK (1989). Occurrence and relevance of chemically induced benign neoplasms in long-term carcinogenicity studiesCancer Metastasis Rev.8: 1-22.
28.
Ito N., Hananouchi M., Sugihara S., Shirai T., Tsuda H., Fukushima S., and Nagasaki H. (1976). Reversibility and irreversibility of liver tumors in mice induced by the α isomer of 1,2,3,4,5,6-hexachlorocyclohexane. Cancer Res.36: 2227-2234.
29.
Jang JJ, Weghorst CW, Henneman JR, Devor DE, and Ward JM (1992). Progressive atypia in spontaneous and N-nitrosodiethylamine induced hepatocellular adenomas of C3H/HeNCr mice. Carcinogenesis13: 1541-1547.
30.
Klaunig JE (1993). Selective induction of DNA synthesis in mouse preneoplastic and neoplastic hepatic lesions after exposure to phenobarbital . Environ. Health Perspect. 101(suppl. 5): 235-240.
31.
Koen H., Pugh TD, and Goldfarb S. (1983a). Hepatocarcinogenesis in the mouse: Combined morphologic-stereologic studies. Am. J. Pathol. 112: 89-100.
32.
Koen H., Pugh TD, Nychka D., and Goldfarb S. (1983b). Presence of alpha-fetoprotein-positive cells in hepatocellular microcarcinomas induced by single injections of diethylnitrosamine in infant mice. Cancer Res. 43: 702-708.
33.
Lee SX-T , Pineau T., Drago J., Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM, Westphal H., and Gonzalez FJ (1995). Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15: 3012-3022.
34.
Lipsky MM, Tanner DC, Hinton DE, and Trump BF (1984). Reversibility, persistence, and progression of safrole-induced mouse liver lesions following cessation of exposure. In: Mouse Liver Neoplasia: Current Perspectives, JA Popp (ed). Hemisphere, New York, pp. 161-177.
35.
Malarkey DE , Devereux TR, Dinse GF, Mann PC, and Maronpot RR (1995). Hepatocarcinogenicity of chlordane in B6C3F1 and B6D2F1 male mice: Evidence for regression in B6C3F1 mice and carcinogenesis independent of ras protooncogene actuation. Carcinogenesis (in press).
36.
Maronpot RRFox T., Malarkey D. and Goldsworthy T. (1995). Mutations in the ras proto-oncogene: Clues to etiology and molecular pathogenesis of mouse liver tumors. Tovicology10: 125-156.
37.
Maronpot RR , Haseman JKBoorman GAEustis SERao GN, and Huff JE (1987). Liver lesions in B6C3F1 mice: The national toxicology program, experience and position. Arch. Tovicol. (suppl.)10: 10-26.
38.
Melnick RL (1992). Does chemically induced hepatocyte proliferation predict liver carcinogenesis? FASEB J. 6: 2698-2706.
39.
Merlino G. (1994). Transgenic mice: Designing genes for molecular models. In: The Liver: Biology and Pathobiology, IM Arias, JL Boyer.N Fausto.WB Jakoby.DA Schachter. and DA Shafritz (eds). Raven Press. Ltd.. New York, pp. 1579-1589.
40.
Moore MRDrinkwater NRMiller EC, Miller JA, and Pitot HC (1981). Quantitative analysis of the time-dependent development of glucose-6-phosphatase-deficient foci in the livers of mice treated neonatally with diethyl-nitrosamine. Cancer Res. 41: 1585-1593.
41.
Moore MANakagawa K.Satoh K.Ishikawa T. and Sato K. (1987). Single GST-P positive liver cells-putative initiated hepatocytes. Carcinogenesis8: 483-486.
42.
Muskhelishvili L., Hart RW, Turturro A., and James SJ (1995). Age-related changes in the intrinsic rate of apoptosis in livers of diet-restricted and ad libitum-fed B6C3F1 mice. Am. J. Pathol. 147: 20-24.
43.
Newberne PM, Suphakan V.Punyarit P., and DeCamargo J. (1987). Nongeno toxic mouse liver carcinogens. In: Nongenotoxic Mechanisms in Carcinogenesis, BE Butterworth and TJ Slaga (eds). Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 165-176.
44.
Nims RW, Lubet RA, Jones CR, Mellini DW, and Thomas PE (1993). Comparative pharmacodynamics of CYP2B induction by phenobarbital in the male and female F344/NCr rat. Biochem. Pharmacol. 45: 521-526.
45.
Ohmori T., Rice JM, and Williams GM (1981). Histochemical characteristics of spontaneous and chemically induced hepatocellular neoplasms in mice and the development of neoplasms with gamma-glutamyl transpeptidase activity during phenobarbital exposure. Histochem. J. 13(1): 85-99.
46.
Pietra G., Spencer K., and Shubik P. (1959). Response of newly born mice to a chemical carcinogen . Nature183: 1689.
47.
Pineau T., Fernandez-Salguero P., Lee SST, McPhail T., Ward JM, and Gonzalez FJ (1995). Neonatal lethality associated with respiratory distress in mice lacking cytochrome P450 1A2. Proc. Natl. Acad. Sci. USA92: 5134-5138.
48.
Rabes HM, Bucher T., Hartmann A., Linke I., and Dunnwald M. (1982). Clonal growth of carcinogen-induced enzyme-deficient preneoplastic cell populations in mouse liver. Cancer Res . 42: 3220-3227.
49.
Rao KVN and Vesselinovitch SD (1973). Age- and sex-associated diethylnitrosamine dealkylation activity of the mouse liver and hepatocarcinogenesis. Cancer Res. 33: 1625-1627.
50.
Rice JM (1973). The biological behaviour of transplacentally induced tumours in mice, Vol. 4. In: Transplacental Carcinogenesis , L Tomatis, U Mohr, and W Davis (eds). IARC Scientific Publication, Lyon, France, pp. 71-83.
51.
Roe FJC , Rowson KEK, and Salaman MH (1961). Tumours of many sites induced by injection of chemical carcinogens into newborn mice. A sensitive test for carcinogenesis: The implications for certain immunologic theories . Br. J. Cancer15: 515-518.
52.
Ruebner BH, Bannasch P., Hinton D., Cullen J., and Ward JM (1995). Foci of altered hepatocytes, mouse. In: Monographs on Pathology of Laboratory Animals, TC Jones and U Mohr (eds). Digestive System, 2nd ed. (in press).
53.
Ruebner BH, Gershwin ME, Meierhenry EF, Hsieh LS, and Dunn PL (1984). Irreversibility of liver tumors in C3H mice. J. Natl. Cancer Inst. 73: 493-498.
54.
Sanchez IM and Bull RJ (1990). Early induction of reparative hyperplasia in the liver of B6C3F1 mice treated with dichloroacetate and trichloroacetate. Toxicology64: 33-46.
55.
Sandgren EP (1995). Transgenic mouse models of hepatic growth regulation and hepatocarcinogenesis. In: Liver Regeneration and Carcinogenesis: Molecular and Cellular Mechanisms, R Jirtle (ed). Academic Press, Inc. (in press).
56.
Standeven AM , Wolf DC, and Goldsworthy TL (1995). Promotion of hepatic preneoplastic lesions in male B6C3F, mice by unleaded gasoline. Environ. Health Perspect. 103: 696-700.
57.
Schulte-Hermann R.Timmermann-Trosiener I., and Schuppler J. (1983). Promotion of spontaneous preneoplastic cells in rat liver as a possible explanation of tumor production by nonmutagenic compounds. Cancer Res . 43: 839-844.
58.
Siglin JC, Weghorst CM, and Klaunig JE (1991). Role of hepatocyte proliferation in α-hexachlorocyclohexane and phenobarbital tumor promotion in B6C3F1 mice. Prog. Clin. Biol. Res. 369: 407-416.
59.
Tamano S., Merlino GT, and Ward JM (1994). Rapid development of hepatic tumors in transforming growth factor α transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital. Carcinogenesis15: 1791-1798.
60.
Tarone RE, Chu KC, and Ward JM (1981). Variability in the rates of some common naturally occurring tumors in Fischer344 rats and (C57BL/6N X C3H/HeN)Fi(B6C3F1) mice . J. Natl. Cancer Inst. 66: 1175-1181.
61.
Tatematsu M. , Fukami H., Yamamoto M., Nakanishi H., Masui T., Kusakabe N., and Sakakura T. (1994). Clonal analysis of glandular stomach carcinogenesis in C3H/HeN↔BALB/c chimeric mice treated with N-methyl-N-nitrosourea . Cancer Lett. 83: 37-42.
62.
Thomas GA, Williams D., and Williams ED (1991). Reversibility of the malignant phenotype in monoclonal tumours in the mouse. Br. J. Cancer63: 213-216.
63.
Tomatis L., Aitio A., Wilbourn J., and Shuker L. (1989). Human carcinogens so far identified. Jpn. J. Cancer Res. 80: 795-807.
64.
Tomatis L., Partensky C., and Montesano R. (1973). The predictive value of mouse liver tumour induction in carcinogenicity testing: A literature survey. Int. J. Cancer12: 1-20.
65.
Tsutsui T., Komine A., Huff J., and Barrett JC (1995). Effects of testosterone, testosterone propionate, 17β-trenbolone and progesterone on cell transformation and mutagenesis in Syrian hamster embryo cells. Carcinogenesis16:1329-1333.
66.
Tsuji S., Ogawa K., Takasaka H., Sonoda T., and Mori M. (1988). Clonal origin of gamma-glutamyl transpeptidase-positive hepatic lesions induced by initiation-promotion of ornithine carbamoyltransferase mosaic mice. Jpn. J. Cancer Res. (Gann)79:148-151.
67.
Vesselinovitch SD (1980). Infant mouse as a sensitive bioassay system for carcinogenicity of N-nitroso compounds. In: N-Nitroso Compounds: Analysis, Formation and Occurrence, EA Walker, M Castegnareo , L Gricuite, and M Borzsonyi (eds). IARC Scientific Publication No. 31, Lyon, pp. 645-655.
68.
Vesselinovitch SD (1990). Perinatal mouse liver carcinogenesis as a sensitive carcinogenesis model and the role of the sex hormonal environment in tumor development. Prog. Clin. Biol. Res. 331: 53-68.
69.
Vesselinovitch SD and Mihailovich N. (1984). Kinetics of induction and growth of basophilic foci and development of hepatocellular carcinoma by diethyl-nitrosamine in the infant mouse. In: Mouse Liver Neoplasia: Current Perspectives. CIIT Series, JA Popp (ed). Hemisphere, New York, pp. 61-83.
70.
Vesselinovitch SD, Rao KVN, and Mihailovoch N. (1979). Neoplastic response of mouse tissue during perinatal age periods and its significance in chemical carcinogenesis. J. Natl. Cancer Inst. 51: 239-250.
71.
Ward JM (1980). Morphology of hepatocellular neoplasms in B6C3F1 mice. Cancer Lett. 9: 319-325.
72.
Ward JM (1984). Morphology of potential preneoplastic hepatocyte lesions and liver tumors and a comparison with other species. In: Mouse Liver Neoplasia, JA Popp (ed). Hemisphere, Washington, D.C., pp. 1-26.
73.
Ward JM (1983). Increased susceptibility of livers of aged F344/ NCr rats to the effects of phenobarbital on the incidence, morphology, and histochemistry of hepatocellular foci and neoplasms. J. Natl. Cancer Inst. 71: 815-823.
74.
Ward JM, Rice JM, Creasia D., Lynch P., and Riggs C. (1983). Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethyl-nitrosamine in B6C3F1 mice. Carcinogenesis4: 1021-1029.
75.
Ward JM, Anver MR, Haines DC, and Benveniste RE (1994). Chronic active hepatitis in mice caused by Helicobacter hepaticus. Am. J. Pathol. 145: 959-968.
76.
Ward JM, Diwan BA, Lubet RA, Henneman JR, and Devor DE (1990). Liver tumor promoters and other mouse liver carcinogens . Prog. Clin. Biol. Res. 331: 85-108.
77.
Ward JM, Diwan BA, Ohshima M., Hu H., Schuller HM, and Rice JM (1986). Tumor-initiating and promoting activities of di(2-ethylhexyl) phthalate in vivo and in vitro. Environ. Health Perspect. 65: 279-291.
78.
Ward JM, Fox JG, Anver MR, Haines DC, George CV, Collins MJ Jr, Gorelick PL, Nagashima K., Gonda MA, Gilden RV, Tully JG, Russell RJ, Benveniste RE, Paster BJ, Dewhirst FE, Donovan JC, Anderson LM, and Rice JM (1994a). Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J. Natl. Cancer Inst. 86: 1222-1227.
79.
Ward JM, Griesemer RA, and Weisburger EK (1979). The mouse liver tumor as an endpoint in carcinogenesis tests. Toxicol. Appl. Pharmacol. 51: 389-397.
80.
Ward JM, Lynch P., and Riggs C. (1988). Rapid development of hepatocellular neoplasms in aging male C3H/HeNCr mice given phenobarbital. Cancer Lett . 39: 9-18.
81.
Ward JM, Ohshima M., Lynch P., and Riggs C. (1984). Di(2-ethylhexyl)phthalate but not phenobarbital promotes N-nitrosodiethylamine-initiated hepatocellular proliferation lesions after short-term exposure in male B6C3F1 mice. Cancer Lett . 24: 49-55.
82.
Ward JMPerantoni AO and Santos E. (1989). Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans. Oncogene4: 203-213.
83.
Ward JM, Uno H., Kurata Y.Weshorst CM and Jang J.-J (1993). Cell proliferation not associated with carcinogenesis in rodents and humans. Environ. Health Perspect. 101 (suppl.) 5: 125-136.
84.
Ward JM and Vlahakis G. (1978). Evaluation of hepatocellular neoplasms in mice . J. Natl. Cancer Inst. 61: 807-811.
85.
Williams GM and Weisburger JH (1991). Chemical carcinogenesis. In: Casarett and Doull's Toxicology, MO Amdur.J Doull, and CD Klassen (eds). Pergamon Press, New York , pp. 127-200.
86.
Wiseman RW, Stowers SJ, Miller EC, Anderson MW and Miller JA (1986). Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3F1 mouse. Proc. Natl. Acad. Sci. USA83: 5825-5829.
87.
Yamamoto R. , Iishi H., Tatsuta M., Tsuji M., and Terada N. (1991). Roles of ovaries and testes in hepatocellular tumorigenesis induced in mice by 3'-methyl-4-dimethylaminoazobenzene . Int. J. Cancer49: 83-88.
